MedPath

EVERMAX NUTRICEUTICAL PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

9

TGA:9

Drug Approvals

Mennify (475969)

Product Name
Mennify
Approval Date
Jan 16, 2025
TGA

EVERMAX NORISHEER (467405)

Product Name
EVERMAX NORISHEER
Approval Date
Nov 6, 2024
TGA

Evermax Dyneaway (467406)

Product Name
Evermax Dyneaway
Approval Date
Nov 6, 2024
TGA

NORISHEER (465033)

Product Name
NORISHEER
Approval Date
Oct 21, 2024
TGA

DyneAway (465034)

Product Name
DyneAway
Approval Date
Oct 21, 2024
TGA

EverMax Dyneaway (422951)

Product Name
EverMax Dyneaway
Approval Date
Sep 28, 2023
TGA

EverMax MetaDyne (400174)

Product Name
EverMax MetaDyne
Approval Date
Nov 25, 2022
TGA

Mennugen (316897)

Product Name
Mennugen
Approval Date
Apr 26, 2019
TGA

Emmugen (316896)

Product Name
Emmugen
Approval Date
Apr 26, 2019
TGA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.